On This Page – Quick Medical Summary
Who this page is for, and who it is not
You are under 35, and something has made you wonder whether you should already have been tested. Maybe a parent was diagnosed, maybe a quiz told you your risk was high, or maybe you asked and were told you were too young.
Diabetes screening under 35 is not one rule with one answer, which is why the pages you have already read disagree. Find yourself below and go straight to that section.
- You have a family history, or a risk quiz flagged you — start at the two lists.
- You take a long-term medication — go to the routes that have nothing to do with weight.
- You had gestational diabetes, at any point in the past — go to the pregnancy section.
- You were told “prediabetes” once and heard nothing since — go to that section.
- You are helping someone under 35 ask the question — the questions at the end are the useful part.
If you have symptoms right now
This page is about screening, which by definition means testing someone who has no symptoms. If you are unusually thirsty, urinating far more than normal, losing weight without trying, or extremely tired, that is a different situation and a faster one.
⚠️ Clinical Warning: Screening recommendations are written for people without symptoms. If you have symptoms that could point to high blood sugar, do not wait for a screening interval or a birthday — contact a clinician the same day and say which symptoms you have and how long they have lasted. Symptomatic testing is diagnostic testing, and it follows a different path entirely.
If someone already told you prediabetes
Then a recommendation already applies to you and it is not an age-based one. Skip ahead — that section is written for you.
ℹ️ Medical Disclaimer: This article is general health education about screening recommendations: it does not diagnose any condition, does not tell you whether you personally should be tested, does not advise starting, stopping or changing any medication, dose or treatment, and makes no claim about what your insurance will or will not pay. Screening decisions, medication decisions and the interpretation of any result belong to a licensed clinician who knows your history — consult a board-certified primary care physician, or the clinician who prescribes for you, before acting on anything here.
Under 35, there is no starting age to be under
There is no minimum age below which diabetes testing is not done. That sounds like a technicality until you read how the current clinical standards are actually ordered.
What the guideline actually says first
The American Diabetes Association’s Standards of Care state the risk-based rule first. Testing for prediabetes or type 2 diabetes should be considered in adults of any age who have overweight or obesity and who have one or more additional risk factors.
Only after that does the guideline say that for all other people, screening should begin at age 35. That word — other — is doing real work. In the guideline’s own ordering, the under-35 pathway is the first rule, and 35 is what applies to everyone the first rule does not already cover.
Almost every page you will read reverses this. It presents 35 as the rule and everything younger as an exception carved out of it.
Where 35 comes from, and where to read about it
The U.S. Preventive Services Task Force also lands on 35, but its recommendation is written for non-pregnant adults aged 35 to 70 with overweight or obesity and no symptoms. Adults under 35 sit outside the stated scope of that recommendation.
That is a statement about what the recommendation covers, not a recommendation against testing younger adults. The two are easy to confuse and they are not the same thing.
Which body publishes which age, and why one federal page still shows an older number, is a separate question with a separate answer — that is covered in which age each guideline publishes. This page is about the pathways that carry no age at all. For how the test itself is read once it is done, see how an A1C result is read.
What about children and teenagers
Children and adolescents have their own rule with entirely different inputs, and it does not work like the adult one. It is covered in testing in children and teenagers, and nothing on this page should be applied to someone under 18.
📊 Clinical Data Point: More than 2 in 5 U.S. adults have prediabetes — Source: CDC, The Surprising Truth About Prediabetes (page displays 15 May 2024). Prediabetes commonly produces no symptoms at all, which is why screening exists as a separate activity from diagnosis, and why CDC’s national diabetes figures are updated as new survey data arrive.
Two lists that look the same and are not
Here is the part almost nobody explains. Two authoritative sources publish nearly the same risk factors for type 2 diabetes, and they combine them with different logic. That is why you can read both and come away with two different answers about yourself.
What CDC’s list is for
CDC tells the public to talk to a doctor about getting blood sugar tested if you have any risk factors, and then lists them: having overweight, being 45 or older, having a parent or sibling with type 2 diabetes, being physically active less than three times a week, ever having had gestational diabetes, and giving birth to a baby who weighed more than nine pounds. Race and ethnicity are named as factors too.
Read that list as it is written and having overweight is one item among several. Any single item is enough to justify raising the question. You can read it yourself on CDC’s list of risk factors worth raising with a doctor.
What the guideline’s rule is for
The Standards of Care rule for adults under 35 is built differently. It applies to adults of any age with overweight or obesity who have one or more additional risk factors.
There, body weight is not one item on a list. It is the gate, and at least one further risk factor is required on top of it.
Why the same six facts give two answers
Consider someone who is 28, at a healthy weight, with a parent who has type 2 diabetes. Reading CDC’s page, they have a risk factor and should raise it. Reading a page built on the clinical rule, the general under-35 pathway does not open for them, because it starts with body weight.
Neither source is wrong, and neither is stricter than the other in any meaningful sense — they are doing different jobs. CDC’s list is a public-health prompt designed to start a conversation with a clinician. The guideline’s rule is a testing threshold written for that clinician to apply once the conversation is happening.
🩺 Physician Note: A risk-factor list and a testing threshold are different instruments, and confusing them is the most common way readers mis-place themselves. Current guidance treats overweight and obesity as the strongest single risk factors for type 2 diabetes, which is why they anchor the clinical rule — but a public-health list is deliberately broader than a testing threshold, because its purpose is to prompt a discussion rather than to authorize a test.
What neither list can settle
Neither one tells you whether you personally should be tested. Both are inputs to a decision a clinician makes with your full history in front of them, including things no list captures.
Risk factors also tend to arrive together rather than singly, which is a pattern in its own right — see how risk factors cluster together.
✅ Patient Action: At your next appointment with a primary care physician, name the specific factor you have and ask: “I have [this factor] — does any screening recommendation apply to me at my age, and if not, is there a reason to test anyway?” That question is answerable. “Should I get tested?” usually is not.
The routes that have nothing to do with weight
The weight-gated pathway is the famous one. It is not the only one, and the others are the reason this page exists — because a young adult at a healthy weight can meet none of the criteria above and still have a standing screening recommendation attached to them.
Medicines that come with a screening recommendation
The Standards of Care advise considering screening for prediabetes or diabetes in people taking certain medications, naming statins, thiazide diuretics and some HIV medicines as classes known to raise the risk of these conditions.
For second-generation antipsychotics the guidance is more specific: screen at the start, repeat 12 to 16 weeks after starting the medication or sooner if clinically indicated, and then annually. No part of that carries an age condition or a weight condition.
Long-term or repeated glucocorticoid use also comes with advice to monitor glucose. If you take one of these long term, the recommendation exists whether or not any of Section 3 applies to you.
This is not unique to diabetes testing. Several drug classes come with routine bloodwork attached for other reasons entirely, mapped out in which medications come with routine blood monitoring.
If you are on treatment for HIV
The guidance here is unusually concrete. People with HIV are advised to have a fasting glucose test before starting antiretroviral therapy, again when therapy is switched, and again three to six months after starting or switching. If that first result is normal, annual testing is advised.
Again: no age term, no weight term.
After an episode of pancreatitis
Screening is advised within three to six months of an episode of acute pancreatitis and annually after that. For chronic pancreatitis, annual screening is advised. Pancreatitis is not rare in younger adults, and this pathway is almost never mentioned on pages about screening ages.
Why none of this is a reason to stop anything
This section is about tests, not about your prescription.
⚠️ Clinical Warning: Learning that a medicine is associated with higher diabetes risk is not a reason to stop it, skip doses, or lower it on your own. On statins specifically, current standards are explicit: glucose status should be monitored in people at high risk, and it is not recommended that statins be avoided or discontinued because of this effect. The condition the medicine treats does not pause while you reconsider it, so raise this with the clinician who prescribed it and keep taking it until they tell you otherwise.
The same principle applies to antipsychotics, HIV therapy and steroids, where stopping abruptly carries its own serious risks. Where a statin sits in the wider risk picture is discussed in what a statin decision actually weighs.
✅ Patient Action: Ask the clinician who prescribes for you — not a new provider who does not hold your medication list — “You prescribe [this medicine] for me. Is there a glucose or A1C check that should go with it, and when was my last one?” Bring the medication name; do not rely on them remembering.
If you have been pregnant, a rule may already apply
Gestational diabetes is one of the clearest examples of a screening pathway that has nothing to do with how old you are. It is also one of the most commonly dropped, because the recommendation outlives the pregnancy by decades and very few people are told so.
The check that comes a few weeks after birth
Current standards advise that people who had gestational diabetes be screened for prediabetes or diabetes at four to twelve weeks after delivery, using an oral glucose tolerance test read against non-pregnancy criteria.
That is a specific window, and it sits in a period when most attention is elsewhere.
The one that does not stop
The recommendation that matters most here is the long one. People with a history of gestational diabetes are advised to have lifelong screening for prediabetes or diabetes, every one to three years.
Lifelong means exactly that — it does not expire when the child starts school, and it does not depend on your weight or your age. It also does not mean you will develop diabetes. It means a recurring check is recommended, indefinitely, for a group whose risk is known to be higher.
If you were never told this, that is common, and it is not something you failed to do.
Testing during pregnancy itself works differently and is covered separately in testing during pregnancy.
If you are planning a pregnancy
Standards advise screening people with risk factors who are planning a pregnancy, and considering testing anyone of childbearing potential for undiagnosed prediabetes or diabetes beforehand. This is one of the few places where testing is suggested ahead of a life event rather than after one.
🩺 Physician Note: The postpartum check and the lifelong interval are two separate recommendations, and having had the first does not discharge the second. A single normal result at the postpartum visit is a snapshot of that moment, which is precisely why the guidance attaches a recurring interval to it rather than closing the file.
If you have already been told prediabetes
If a clinician has ever told you your blood sugar was borderline, a recommendation already applies to you — and it is more frequent than the one for the general population.
What the guideline schedules after a borderline result
For people with prediabetes, current standards advise monitoring for the development of diabetes at least annually, with the frequency adjusted according to individual risk.
Annually. Not once, not when you next happen to have blood drawn, and not on the schedule that applies to people who have never had a borderline result. This is the single interval on this page that belongs to a population rather than to an age — which is why it survives being under 35.
How often testing is repeated in other situations, and what changes an interval, is covered in how often testing is repeated.
What the result itself does not settle
A borderline result is a prompt for a next step, not a verdict, and what that next step looks like depends on the whole picture rather than the number alone — what a borderline result leads to covers what usually follows.
A prediabetes result is also the entry point to a structured prevention program, which CDC describes in its prevention program guidance.
✅ Patient Action: Ask a primary care physician “I was told prediabetes in [year] — when was I last re-checked, and when is the next one due?” If the answer is that nobody has checked since, that is the appointment worth making.
What this page cannot tell you about your own case
There are three things this page deliberately does not do, and the reasons are worth having.
Why we do not publish a checklist you can score
You will find pages that offer a tick-box list so you can work out whether you qualify. We do not, because Section 3 is the reason: the same factors combine differently depending on which document you are reading, and a checklist has to pick one and hide the other. A score you calculate from a list you found online is not an eligibility decision, and treating it as one leads people to rule themselves out.
Why we do not recommend an at-home kit
We link no at-home testing kit here and earn nothing from one. Results from point-of-care devices are not intended for diagnosing diabetes, and CDC advises following up with a clinician after a result from a health fair or a pharmacy. A kit can tell you a number but not which pathway applies to you, and CDC’s guidance on testing for diabetes sets out what the tests are and where they are done.
If you are told you are too young
That answer may be a correct reading of the general age rule, and it may also have been given without the other pathways in view. The productive move is not to argue the age — it is to name the specific pathway you think applies, because that is a different conversation.
Whether a test is covered, and why a preventive lab can still generate a bill, is a separate matter covered in which rule your plan follows and why a preventive lab can still generate a bill.
Three questions worth asking
- “Does any current screening recommendation apply to me, given my history and what I take?”
- “If none applies, is there still a reason to check once and establish a baseline?”
- “If we do test, what happens next depending on the result?”
The third one is the one people forget, and it is the one that stops a result arriving with no plan attached to it.
Questions people ask about testing under 35
1. Can you be screened for diabetes before 35?
Yes. Diabetes screening under 35 is provided for directly in current clinical standards, which state the risk-based rule before the age-based one and apply it to adults of any age with overweight or obesity plus one or more additional risk factors. Several further pathways carry no age condition at all. Whether one applies to you is a decision for your clinician.
2. Why do guidelines start at 35?
Thirty-five is the point at which the general, non-risk-based recommendation begins. The task force lowered its starting age to 35 based on evidence that diabetes becomes more common at that age compared with younger ages. It is a starting point for people no other pathway already covers, not a minimum age for testing.
3. Do I have to have overweight or obesity to be tested early?
For the general under-35 pathway in the clinical standards, body weight is the gate and an additional risk factor is required alongside it. Other pathways described on this page — certain medications, a gestational diabetes history, an earlier borderline result — carry no weight condition. Ask your clinician which, if any, applies to you.
4. CDC lists risk factors — does having one mean I get tested?
Not automatically. CDC’s list is written to prompt a conversation, and it says to talk to a doctor if you have any of the risk factors it names. The clinical testing rule is written for the clinician and combines the same factors differently. One is an invitation to ask; the other is a threshold to apply.
5. Can a medication be the reason I’m screened?
Yes. Current standards advise considering screening for prediabetes or diabetes in people taking statins, thiazide diuretics and some HIV medicines, and give a specific schedule for second-generation antipsychotics — at the start, 12 to 16 weeks in, then annually. Long-term or repeated glucocorticoid use also comes with monitoring advice. Discuss the schedule that fits your own prescription with the clinician who prescribes it.
6. Should I stop a medication that raises diabetes risk?
No. On statins, the standards say plainly that glucose should be monitored and that statins should not be avoided or discontinued because of this effect. The same caution applies to antipsychotics, HIV therapy and steroids, where stopping carries its own risks. Raise it with the clinician who prescribed it and keep taking it until advised otherwise.
7. I had gestational diabetes — is testing still recommended years later?
Yes. Current standards advise lifelong screening for prediabetes or diabetes every one to three years after a gestational diabetes pregnancy, separately from the check advised at four to twelve weeks postpartum. The recommendation does not expire and does not depend on your age. Ask your clinician when your last check was.
8. I was told prediabetes in my twenties — what now?
A recommendation already applies: standards advise monitoring at least annually for the development of diabetes, with frequency adjusted to individual risk. Being under 35 does not change that, because the interval belongs to the prediabetes finding rather than to your age. Ask a primary care clinician when you were last re-checked and when the next one is due.
9. What if my clinician says I’m too young?
That may be an accurate reading of the general age rule. The more useful response is to name the specific pathway you think applies — a medication you take, a gestational diabetes history, an earlier borderline result — rather than to dispute the age itself. Those pathways are separate from the age rule and are answerable individually.
10. Does being under 35 mean it won’t be covered?
Coverage follows rules set separately from the clinical standards described here, and this page makes no claim about what any plan will pay. Whether a test is covered without cost-sharing depends on which recommendation your plan follows and how the test is ordered. Ask the ordering clinician and your plan directly before assuming either way.
11. What about children and teenagers?
Nothing on this page applies to anyone under 18. Children and adolescents have a separate rule with different inputs — it is triggered by puberty or a specific age, whichever comes first, together with growth-chart measures and risk factors. That rule is covered on our dedicated page for testing in children and teenagers.
What to do with this before your next appointment
If one of the pathways on this page describes you, the useful next step is not to request a particular test. It is to name the pathway.
“I take a second-generation antipsychotic” or “I had gestational diabetes in 2021” or “I was told prediabetes three years ago” each puts a specific, answerable question in front of a clinician. Being under 35 does not close any of those conversations, and in the guideline’s own ordering it never did.
For what the test measures and how a result is read once you have one, start with how an A1C result is read.
Write down the one sentence that applies to you before the appointment. That sentence is the whole task.
About this content
How this article was put together: researched from recognised health sources, drafted with the help of AI tools, and edited by hand, with sources linked throughout.
Sameer Patel is the founder and editor of My Medicine Advisor. He is not a doctor or medical professional — before starting this site he worked in banking,…
Medical disclaimer
The content on MyMedicineAdvisor is provided for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Health information on this website should not be used to diagnose, treat, cure, or prevent any condition without guidance from a qualified healthcare professional. Always seek the advice of your doctor, physician, or another licensed healthcare provider with any questions you may have regarding a medical condition, symptoms, medications, or treatment decisions.
